Sep 3, 2026 04:10AM
Jan 12, 2026 07:31AM
Jan 12, 2026 07:30AM
Jan 7, 2026 04:05PM
Jan 12, 2025 11:00AM
Jan 6, 2025 04:30PM
Sep 30, 2024 08:30AM JPMorgan refreshed its U.S. Analyst Focus List, adding these six stocks
Sep 25, 2024 11:00AM
Sep 17, 2024 02:00PM
Jun 13, 2024 08:49PM
Jun 12, 2024 04:05PM
Jun 12, 2024 04:05PM
Jan 8, 2024 05:20AM
Jan 7, 2024 11:00AM Ultragenyx Reports Preliminary 2023 Revenue; Guidance for 2024 Revenue and Cash Usage; Pipeline Updates and 2024 Milestones
Jan 2, 2024 04:05PM
Oct 23, 2023 04:01PM
Oct 19, 2023 05:49AM
Oct 18, 2023 09:16PM
Oct 17, 2023 04:03PM
Oct 17, 2023 04:02PM
Jan 6, 2023 04:02PM Ultragenyx Pharma (RARE) Reports Prelim 2022 Revenue of $352M-$356M; Guides 2023 Revenue of $425M-$450M
Jan 6, 2023 04:01PM
Jan 6, 2023 04:01PM
Jan 4, 2023 06:00AM
Jan 4, 2023 06:00AM
Mar 16, 2022 06:47AM
Feb 11, 2022 04:28AM
Jan 10, 2022 09:14AM Ultragenyx Pharma (RARE) Reports Prelim 2021 Revenue, Provides 2022 Revenues Guidance and Pipeline Updates
Jan 10, 2022 08:00AM
Jan 10, 2022 08:00AM
Jan 3, 2022 04:01PM
Jan 3, 2022 04:01PM
Feb 12, 2021 07:35AM
Jan 11, 2021 07:06AM
Jan 11, 2021 07:00AM Ultragenyx Reports Preliminary 2020 Revenue and 2021 Revenue Guidance for Crysvita in Ultragenyx Territories
Jan 11, 2021 07:00AM
Jan 5, 2021 08:31AM
Jan 5, 2021 08:31AM
Nov 2, 2020 11:20AM
Nov 2, 2020 11:20AM
Oct 29, 2020 05:54AM
Oct 28, 2020 07:00PM Ultragenyx Announces Pricing of Public Offering of Common Stock
Oct 28, 2020 07:00PM
Oct 28, 2020 07:47AM
Oct 28, 2020 07:47AM
Oct 28, 2020 07:47AM
Jan 13, 2020 08:20AM
Jan 13, 2020 08:10AM
Jan 13, 2020 08:10AM Ultragenyx Reports Preliminary 2019 Revenue and Provides 2020 Crysvita Revenue Guidance
Dec 19, 2019 08:30AM

297,016 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All